Long-term impact of fecal transplantation in healthy volunteers

BACKGROUND: Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effectiveness of its application in the other gastrointestinal d...

Descripción completa

Detalles Bibliográficos
Autores principales: Goloshchapov, Oleg V., Olekhnovich, Evgenii I., Sidorenko, Sergey V., Moiseev, Ivan S., Kucher, Maxim A., Fedorov, Dmitry E., Pavlenko, Alexander V., Manolov, Alexander I., Gostev, Vladimir V., Veselovsky, Vladimir A., Klimina, Ksenia M., Kostryukova, Elena S., Bakin, Evgeny A., Shvetcov, Alexander N., Gumbatova, Elvira D., Klementeva, Ruslana V., Shcherbakov, Alexander A., Gorchakova, Margarita V., Egozcue, Juan José, Pawlowsky-Glahn, Vera, Suvorova, Maria A., Chukhlovin, Alexey B., Govorun, Vadim M., Ilina, Elena N., Afanasyev, Boris V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938016/
https://www.ncbi.nlm.nih.gov/pubmed/31888470
http://dx.doi.org/10.1186/s12866-019-1689-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938016/
https://www.ncbi.nlm.nih.gov/pubmed/31888470
http://dx.doi.org/10.1186/s12866-019-1689-y

Ejemplares similares